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Myeloid cells are key targets of human immunodeficiency
virus (HIV) replication in vivo and are important players in
viral-induced pathogenesis. Albeit with variations
depending on their differentiation status, these cells are
less susceptible to viral infection than other cell types like
primary lymphocytes and established cell lines ex vivo.
This resistance is obviously exerted at multiple levels, yet
a major restriction during lentiviral infection occurs dur-
ing the early steps of infection, that is, during those steps
comprised between viral entry and viral DNA integration.
To date, a single viral non structural protein has been
identified as capable of removing this restriction in pri-
mary myeloid cells, the Vpx protein. Vpx is coded by
members of the SIVSM/HIV-2 lineage, but is absent in HIV-
1 and in most of the remaining SIV lineages. We have
already shown that Vpx is not only required for the com-
pletion of infection by the parental HIV-2 and SIVSM
viruses, but also that Vpx exerts a positive effect during the
infection of myeloid cells with a number of distantly
related lentiviruses, like HIV-1, FIV and EIAV. In all these
cases, Vpx promoted the accumulation of complete viral
DNA and this accumulation correlated with an increased
efficacy of infection.
The effect of Vpx has been linked to the action of an E3
ubiquitin ligase complex, but this action remains contro-
versial and the mechanism and the effects through which
it may be exerted are unclear. In an effort to understand
the mechanistic role of Vpx in the removal of the restric-
tion to lentiviral infection existing in myeloid cells, we
have performed a wide analysis of the post-translational
modifications that over the years have been described for
Vpx, ubiquitination, phosphorylation, and so forth and
we have tried to correlate these properties to the function-
ality of Vpx proteins during the early steps of infection.
These and other results will be presented here.
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